Malinowska B, Chabielska E, Pietraszek M H, Buczko W
Department of Pharmacodynamics, Medical School, Białystok, Poland.
Haemostasis. 1990;20(1):48-53. doi: 10.1159/000216104.
The influence of captopril on blood platelet aggregation and on serotonergic mechanisms in blood platelets were studied. In rats pretreated with captopril (10.0 mg/kg p.o.) platelet aggregation induced by ADP and collagen was significantly reduced. In vitro this drug had no inhibitory effect. Besides, captopril did not change the amplifying effect of serotonin on platelet aggregation. Captopril also had no influence on the uptake and storage of 5-hydroxytryptamine by rat blood platelets. These results show that serotonergic mechanisms are not involved in the suppressive effect of captopril on platelet aggregation.
研究了卡托普利对血小板聚集及血小板中5-羟色胺能机制的影响。在经卡托普利(10.0mg/kg口服)预处理的大鼠中,由ADP和胶原诱导的血小板聚集显著降低。在体外,该药物无抑制作用。此外,卡托普利不改变5-羟色胺对血小板聚集的增强作用。卡托普利对大鼠血小板摄取和储存5-羟色胺也无影响。这些结果表明,5-羟色胺能机制不参与卡托普利对血小板聚集的抑制作用。